The outlook of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced considerable risk . Investors are now assessing the effect of lower-cost alternatives, shrinki